The present study aimed to elucidate the effect of 10 mg/kg Δ9-tetrahydrocannabinol (THC) on cerebellar neuronal and glial morphology, apoptosis and inflammatory gene expression using a series of histological assays including stereology, Sholl analysis, immunofluorescence and real-time qPCR in male Wistar rats. A decrease in the number of Purkinje neurons and the thickness of the granular layer in the cerebellum was reported in THC-treated rats. Increased expression of Iba-1 and arborization of microglial processes were evidence of microgliosis and morphological changes in microglia. In addition, astrogliosis and changes in astrocyte morphology were other findings associated with THC administration. THC also led to an increase in caspase-3 positive cells and a decrease in autophagy and inflammatory gene expression such as mTOR, BECN1 and LAMP2. However, there were no significant changes in the volume of molecular layers and white matter, the spatial arrangement of granular layers and white matter, or the spatial arrangement of granular layers and white matter in the cerebellum. Taken together, our data showed both neuroprotective and neurodegenerative properties of THC in the cerebellum, which require further study in the future.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734605 | PMC |
http://dx.doi.org/10.1093/toxres/tfad098 | DOI Listing |
Background: MRI offers potential noninvasive detection of Alzheimer's micropathology. The AD hippocampus exhibits microscopic pathological changes such as tau tangles, iron accumulation and late-stage amyloid. Validating these changes from ultra-high-resolution ex-vivo MRI through histology is challenging due to nonlinear 3D deformations between MRI and histological samples.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
West China Hospital of Sichuan University, Chengdu, China.
Background: Alzheimer's disease (AD) and Frontotemporal dementia (FTD) are the two most common causes of early-onset dementia. Differentiating between AD and FTD can be challenging due to overlapping cognitive and behavioral manifestations. However, evidence on non-invasive and early-stage biomarkers for differentiating AD and FTD is still limited.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands.
Background: Commissural tracts are the white matter fibre bundles intercommunicating left and right brain hemispheres. They integrate many cognitive functions such as memory, verbal processing, motor and perceptual skills. Also, commissures connect specific layers of cortical neurons that are also lost in Alzheimer's disease (AD) and other neurodegenerative disorders.
View Article and Find Full Text PDFBackground: Hippocampal Sclerosis of aging (HS) refers to age-related selective neuronal loss and gliosis in hippocampal cornu ammonis 1 (CA1) and subiculum that is out of proportion to tau pathology in Alzheimer's Disease (AD). HS is related to cognitive decline and memory impairments separately from other neurodegenerative pathologies. To date, in vivo imaging biomarkers of HS of aging are non-existent, and their development would greatly improve diagnosis and prognosis in memory clinics.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Background: Cardiometabolic disorders are emerging risk factors for Alzheimer's disease (AD) and AD-related dementia (ADRD). There is currently insufficient understanding of how different cardiometabolic profiles and blood biomarkers impact different AD-related brain pathology regionally. This project uses data-driven approaches and explainable artificial intelligence methods to determine the cardiometabolic and fluid contributions toward AD-related pathophysiologic patterns in the brain.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!